Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

7:07 AM ET 8-K
Clinical Trial Data Corbus Pharmaceuticals Holdings, Inc. CRBP

Corbus Pharmaceuticals Holdings Clinical Trial Data

Corbus Pharmaceuticals announced positive topline results from its CANYON-1 Phase 1b clinical trial of CRB-913 for the treatment of obesity. The study met its primary objectives, demonstrating statistically significant weight loss of 5% at the 60 mg dose over 12 weeks with a favorable safety profile and no evidence of weight loss plateauing. The data supports CRB-913's potential as a first-in-class oral, non-incretin obesity medicine.

Term
16 weeks
Earnings call
Sep 14, 2026, 8:00 AM ET
7:04 AM ET 8-K
Loan & Debt Bally's Corp BALY

Bally's $560M Debt Financing with WhiteHawk Capital Partners, LP

Bally's Corporation entered into a senior secured term loan agreement for up to $560 million, consisting of a $400 million initial commitment and a $160 million delayed draw facility. The financing, led by WhiteHawk Capital Partners, will fund pre-construction costs for the Bally's Bronx project and provide general corporate liquidity. The loans bear interest at Term SOFR plus 8.50% and mature 18 months after initial funding.

Value
$560M
Counterparty
WhiteHawk Capital Partners, LP
Term
18 months
7:01 AM ET 8-K
Leadership Change Flowserve Corp FLS

Flowserve Leadership Change

Flowserve Corporation announced that Amy B. Schwetz will resign as CFO on September 30, 2026, to join another public company. Brian Ezzell, currently VP of FP&A, Treasurer, and Investor Relations, has been appointed as the new Senior Vice President and CFO effective October 1, 2026. Ezzell will receive a base salary of $625,000 and a target annual long-term incentive award of $1.6 million starting in 2027.

6:55 AM ET 8-K
Divestiture Hain Celestial Group Inc HAIN

Hain Celestial Group Divestiture to Aurelius for $323M

Hain Celestial has entered into a definitive agreement to sell its International business operating in the UK, Ireland, and Europe to affiliates of private equity firm AURELIUS for approximately $323.2 million (£238.5 million). The transaction includes brands such as Ella’s Kitchen, Joya, and Hartley’s, with net proceeds intended to reduce the company's indebtedness. Closing is contingent on regulatory approvals and an amendment to the company's credit agreement to extend its December 2026 maturity date.

Value
$323M
Counterparty
AURELIUS
Earnings call
Sep 14, 2026, 8:00 AM ET

“Fiscal 2026 was a pivotal year for Hain. We simplified our portfolio, reduced debt, significantly improved free cash flow and exited the year with improving momentum across the business.”

Alison Lewis, President and CEO

“Assuming we successfully complete the transaction announced today to sell our International business and that we reach an agreement with our lenders to extend of our December debt maturity, we would expect to become a more focused North American company with leading brands in attractive categories and a streamlined operating model.”

Alison Lewis, President and CEO
6:43 AM ET 8-K
Loan & Debt Toyota Motor Credit Corp

Toyota Motor Credit Debt Financing Update with The Bank of New York Mellon

Toyota Motor Credit Corporation (TMCC) renewed its Euro Medium Term Note (EMTN) Programme for a one-year period, allowing for the issuance of unsecured notes. The program has an aggregate authorized principal amount of €60 billion shared among TMCC and its affiliates in the Netherlands, Canada, and Australia. The renewal included entering into amended and restated agency agreements with The Bank of New York Mellon to facilitate the issuance of notes in bearer or registered form.

Counterparty
The Bank of New York Mellon
Term
1 year
6:35 AM ET 8-K
Investor Presentation American Healthcare REIT, Inc. AHR

American Healthcare REIT Investor Presentation

American Healthcare REIT, Inc. released a formal investor presentation on September 14, 2026, for use in upcoming meetings with investors and stakeholders. The presentation was made available on the company's investor relations website and incorporated into the SEC filing under Item 7.01.

6:34 AM ET 8-K
Leadership Change State Street Corp STT

State Street Leadership Change

State Street Corporation announced two executive leadership appointments effective immediately: Mostapha Tahiri as President of State Street Alpha and Ann Fogarty as Enterprise Chief Operating Officer. Ms. Fogarty, who previously served as Investment Services COO, will have a target incentive compensation award of $5.65 million in her new role.

6:21 AM ET 8-K
Capital Raise Addentax Group Corp. ATXG

Addentax Group Capital Raise of $2.5M

Addentax Group Corp. entered into a private placement agreement with investor Chan Chun Hong to sell 520,834 shares of common stock at $4.80 per share. The transaction is expected to generate gross proceeds of approximately $2.5 million, which the company intends to use for general corporate purposes and strategic investments.

Value
$2.5M
Counterparty
Chan Chun Hong
6:20 AM ET 8-K
Research Collaboration Perspective Therapeutics, Inc. CATX

Perspective Therapeutics Research Collaboration with Merck

Perspective Therapeutics has entered into a clinical trial collaboration and supply agreement with Merck to evaluate its targeted alpha-particle therapy [212Pb]PSV359 in combination with Keytruda. The combination will be tested in an ongoing Phase 1/2a study for FAP-alpha positive solid tumors, with Perspective sponsoring the study and Merck providing pembrolizumab at no cost.

Counterparty
Merck
6:16 AM ET 8-K
Clinical Trial Data Lipocine Inc. LPCN

Lipocine Clinical Trial Data

Lipocine Inc. announced the initiation of BLOOM, a Phase 3 clinical study evaluating LPCN 1154 (oral brexanolone) for the treatment of postpartum depression. The study aims to enroll approximately 120 participants with first dosing expected in early Q4 2026, following exploratory findings from a prior trial that suggested rapid symptom relief.

6:15 AM ET 8-K
Deal Termination Embrace Change Acquisition Corp. EMCGF

Embrace Change Acquisition Deal Termination with Tianji Tire Global Limited

Embrace Change Acquisition Corp. (EMCG) received a termination notice from Tianji Tire Global (Cayman) Limited regarding their previously announced merger agreement. The deal was terminated because the merger was not consummated by the 'Outside Date' of August 12, 2026, as permitted under the terms of the agreement.

Counterparty
Tianji Tire Global (Cayman) Limited
6:04 AM ET 8-K
Investor Presentation WhiteFiber, Inc. WYFI

WhiteFiber Investor Presentation

WhiteFiber, Inc. filed a formal investor presentation deck as of September 2026 to provide an overview of its AI infrastructure, data center, and cloud solutions business. The presentation outlines the company's strategy for scaling operations, acquiring new data centers, and commercializing its services for AI workloads.

6:03 AM ET 8-K
Other 8-K Filing Oracle Corp ORCL

Oracle Other 8-K Filing

Oracle Executive Chair and CTO Larry Ellison has cancelled his 10b5-1 trading plan to sell company stock. No shares were sold under the plan prior to its termination, and Ellison stated he has no other current plans to sell any of his Oracle holdings.

Counterparty
Larry Ellison
6:03 AM ET 8-K
Product Launch Artificial Intelligence Technology Solutions Inc. AITX

Artificial Intelligence Technology Solutions Product Launch

Artificial Intelligence Technology Solutions (AITX) announced that its RAD subsidiary has commercially launched the integration of its ROSA and RIO security platforms with the Immix monitoring ecosystem. The integration allows major guarding and monitoring companies to manage RAD's AI-driven security devices directly within their existing Immix workflows. The company is currently engaging with the nation's largest security providers for evaluation and deployment.

Counterparty
Immix
6:03 AM ET Form 4
Insider Buying Neonc Technologies Holdings, Inc. NTHI

Neonc Technologies Holdings CEO, President Amir F. Heshmatpour Buys $136K of Stock

Amir F. Heshmatpour, CEO, President, bought 37,000 shares of Neonc Technologies Holdings, Inc. at $3.67 a share, worth $136K in total on Sep 11, 2026. Shares held after the trade: 3,133,000 (+1.2%).

Value
$136K
Shares
37,000
Price
$3.67
Role
CEO, President
Holding change
+1.2%
Trade date
Sep 11, 2026
6:02 AM ET 8-K
Shareholder Meeting Polaryx Therapeutics, Inc. PLYX

Polaryx Therapeutics Shareholder Meeting

Polaryx Therapeutics held its Annual Meeting of Stockholders on September 10, 2026, where shareholders elected Alex Yang and Mitchel Berger as Class I Directors to serve until 2029. Additionally, the appointment of Grant Thornton LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.

6:02 AM ET 8-K/A
Investor Presentation Biolargo, Inc. BLGO

Biolargo Investor Presentation

BioLargo, Inc. filed an amendment to its Form 8-K to include a transcript of an investor webcast held on September 10, 2026. The filing includes the company's slide deck presentation and a verbatim transcript of the management presentation to investors and analysts.

6:01 AM ET 8-K
Capital Raise abrdn Global Infrastructure Income Fund ASGI

abrdn Global Infrastructure Income Fund Capital Raise

abrdn Global Infrastructure Income Fund (ASGI) has announced a transferable rights offering for its common shareholders of record as of September 21, 2026. Shareholders will receive one right for every share held, allowing them to subscribe for one new common share for every three rights at a subscription price equal to 92.5% of the average closing market price (or 92.5% of NAV if higher). The fund intends to use the additional capital to invest in global infrastructure assets across power, communications, and transportation sectors.

6:01 AM ET 8-K
Other 8-K Filing Biovie Inc. BIVI

Biovie Other 8-K Filing

BioVie Inc. entered into a sales agreement with A.G.P./Alliance Global Partners to establish an at-the-market (ATM) offering program. Under the agreement, the company may issue and sell shares of its Class A common stock having an aggregate offering price of up to approximately $6.46 million from time to time. The company has no obligation to sell any shares and intends to use any potential proceeds for general corporate purposes.

Counterparty
A.G.P./Alliance Global Partners
6:01 AM ET 8-K
Business Update Synchrony Financial SYF

Synchrony Financial Business Update

Synchrony Financial disclosed its monthly credit performance statistics for the thirteen months ended August 31, 2026, reporting a 30+ day delinquency rate of 4.2% and an adjusted net charge-off rate of 4.9%. Period-end loan receivables stood at $103.0 billion, reflecting a slight increase from the prior month. These periodic updates provide investors with visibility into the credit quality and loss trends of the company's consumer loan portfolio.

6:00 AM ET 8-K
Dividend InPoint Commercial Real Estate Income, Inc. ICR-PA

InPoint Commercial Real Estate Income Dividend

InPoint Commercial Real Estate Income, Inc. announced a reduction in its monthly distribution to $0.026 per share for stockholders of record as of September 30, 2026. The board and management decided to lower the rate to better align distributions with the portfolio's current earnings capacity and expected cash flows. Additionally, the company announced it intends to engage an investment bank to explore strategic alternatives to enhance stockholder value and liquidity.

6:00 AM ET 8-K
Leadership Change TransparentBusiness, Inc.

TransparentBusiness Leadership Change

Deniece Ky resigned as the Company’s Principal Accounting Officer and Senior Financial Director, effective September 17, 2026. The resignation was for personal reasons and includes a lump sum payment of $42,755.89 for accrued but unused paid time off.

Counterparty
Deniece Ky
9:10 AM ET 8-K
Financial Results Amrep Corp. AXR

Amrep Financial Results

AMREP Corporation reported financial results for its first fiscal quarter ended July 31, 2026, with revenues of $6.1 million compared to $17.9 million in the prior year period. Net income decreased significantly to $276,000, or $0.05 per diluted share, from $4.7 million in the same quarter of the previous year.

Term
Q1 2027
9:10 AM ET 8-K
Other 8-K Filing Bonk, Inc. BNKK

Bonk Other 8-K Filing

Bonk, Inc. entered into a definitive agreement to redeem and retire 26,667 shares of its Series A Preferred Stock from Core4 Capital Holdings Corp for $4.0 million. As part of the deal, Core4 irrevocably waived all anti-dilution rights and other preferences for its remaining preferred shares, significantly reducing the company's senior equity overhang and de-risking the capital structure for common shareholders.

Counterparty
Core4 Capital Holdings Corp
9:10 AM ET 8-K
Capital Raise Rainier Acquisition Corp RNAQ

Rainier Acquisition Capital Raise of $86.2M

Rainier Acquisition Corporation announced that holders of units from its $86.25 million initial public offering may elect to separately trade the underlying Class A ordinary shares and warrants starting September 14, 2026. The separated securities will trade on Nasdaq under the symbols RNAQ and RNAQW, while unseparated units continue under RNAQU. The IPO, which included the full exercise of the over-allotment option, was led by Chardan Capital Markets.

Value
$86.2M
Counterparty
Chardan Capital Markets LLC
9:10 AM ET 8-K/A
Deal Termination Visium Technologies, Inc. VISM

Visium Technologies Deal Termination

Visium Technologies filed an amendment to a previous 8-K to clarify that four shares of Series G Governing Preferred Stock were never actually issued and no consideration was received. Consequently, the company is withdrawing the Series G designation and terminating related corporate programs, including a remediation plan for Series A and B preferred stock. The board determined that the previous disclosure of the stock issuance was erroneous and has returned the designated shares to the status of authorized but unissued preferred stock.

9:10 AM ET 8-K
Executive Compensation Oportun Financial Corp OPRT

Oportun Financial Executive Compensation

Oportun Financial Corporation has appointed William Franklin as Chief Financial Officer, effective September 8, 2026. Mr. Franklin's compensation package includes a $500,000 base salary, a $200,000 signing bonus, and a new hire equity award of 276,626 restricted stock units (RSUs) vesting over three years.

Counterparty
William Franklin
9:10 AM ET 8-K
Other 8-K Filing Quetta Acquisition Corp QETA

Quetta Acquisition Other 8-K Filing

Quetta Acquisition Corporation deposited $60,000 into its trust account to extend the deadline for completing its initial business combination. The extension moves the deadline from September 10, 2026, to October 10, 2026, providing the SPAC with an additional month to finalize a merger.

Term
1 month
9:10 AM ET 8-K
Shareholder Meeting Peraso Inc. PRSO

Peraso Shareholder Meeting

Peraso Inc. held its 2026 Annual Meeting of Stockholders on September 10, 2026, where shareholders approved an amendment to the 2019 Stock Incentive Plan to increase the share reserve by 1,500,000 shares and re-elected Ronald Glibbery to the Board. Separately, the company announced that CFO James Sullivan will resign effective October 2, 2026, for personal reasons, with CEO Ronald Glibbery assuming the role of interim CFO.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.